Faes Farma Past Earnings Performance
Past criteria checks 4/6
Faes Farma has been growing earnings at an average annual rate of 9.7%, while the Pharmaceuticals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 5.8% per year. Faes Farma's return on equity is 14.2%, and it has net margins of 19.7%.
Key information
9.7%
Earnings growth rate
6.5%
EPS growth rate
Pharmaceuticals Industry Growth | 5.0% |
Revenue growth rate | 5.8% |
Return on equity | 14.2% |
Net Margin | 19.7% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think
Mar 01Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316
Dec 18Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316
Dec 04Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?
Nov 24Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly
May 03Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?
Sep 21Is Faes Farma (BME:FAE) A Risky Investment?
Aug 03Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth
Jun 17Is Faes Farma (BME:FAE) Using Too Much Debt?
Mar 27Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14
Dec 13Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17
Nov 29Is Faes Farma (BME:FAE) A Risky Investment?
Sep 21Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year
Jul 31Is Faes Farma (BME:FAE) Using Too Much Debt?
May 01Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)
Apr 07Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?
Mar 22Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations
Mar 06Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment
Feb 22I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease
Jan 16Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly
Dec 08Revenue & Expenses BreakdownBeta
How Faes Farma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 482 | 95 | 123 | 0 |
31 Dec 23 | 473 | 92 | 122 | 0 |
30 Sep 23 | 472 | 90 | 98 | 0 |
30 Jun 23 | 469 | 90 | 97 | 0 |
31 Mar 23 | 467 | 91 | 96 | 0 |
31 Dec 22 | 462 | 89 | 116 | 0 |
30 Sep 22 | 460 | 86 | 113 | 0 |
30 Jun 22 | 466 | 88 | 91 | 0 |
31 Mar 22 | 449 | 88 | 111 | 0 |
31 Dec 21 | 429 | 82 | 87 | 0 |
30 Sep 21 | 416 | 81 | 107 | 0 |
30 Jun 21 | 398 | 74 | 106 | 0 |
31 Mar 21 | 394 | 73 | 104 | 0 |
31 Dec 20 | 411 | 73 | 105 | 0 |
30 Sep 20 | 408 | 77 | 92 | 0 |
30 Jun 20 | 407 | 73 | 106 | 0 |
31 Mar 20 | 409 | 68 | 106 | 0 |
31 Dec 19 | 383 | 64 | 104 | 0 |
30 Sep 19 | 379 | 60 | 114 | 0 |
30 Jun 19 | 363 | 59 | 97 | 0 |
31 Mar 19 | 351 | 54 | 95 | 0 |
31 Dec 18 | 340 | 52 | 94 | 0 |
30 Sep 18 | 334 | 51 | 87 | 0 |
30 Jun 18 | 330 | 49 | 86 | 0 |
31 Mar 18 | 308 | 47 | 81 | 0 |
31 Dec 17 | 282 | 41 | 77 | 0 |
30 Sep 17 | 266 | 39 | 70 | 0 |
30 Jun 17 | 250 | 39 | 67 | 0 |
31 Mar 17 | 241 | 38 | 66 | 0 |
31 Dec 16 | 237 | 37 | 66 | 0 |
30 Sep 16 | 226 | 35 | 64 | 0 |
30 Jun 16 | 222 | 34 | 63 | 0 |
31 Mar 16 | 220 | 32 | 62 | 0 |
31 Dec 15 | 214 | 30 | 61 | 0 |
30 Sep 15 | 207 | 28 | 59 | 1 |
30 Jun 15 | 203 | 27 | 58 | 0 |
31 Mar 15 | 196 | 26 | 45 | 0 |
31 Dec 14 | 198 | 25 | 58 | 0 |
30 Sep 14 | 195 | 23 | 60 | 1 |
30 Jun 14 | 194 | 24 | 60 | 1 |
31 Mar 14 | 192 | 20 | 60 | 1 |
31 Dec 13 | 193 | 23 | 60 | 1 |
30 Sep 13 | 196 | 21 | 65 | 1 |
30 Jun 13 | 197 | 23 | 65 | 1 |
Quality Earnings: FAE has high quality earnings.
Growing Profit Margin: FAE's current net profit margins (19.7%) are higher than last year (19.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FAE's earnings have grown by 9.7% per year over the past 5 years.
Accelerating Growth: FAE's earnings growth over the past year (4.6%) is below its 5-year average (9.7% per year).
Earnings vs Industry: FAE earnings growth over the past year (4.6%) exceeded the Pharmaceuticals industry 3%.
Return on Equity
High ROE: FAE's Return on Equity (14.2%) is considered low.